TABLE 4.
GM | ||||||
---|---|---|---|---|---|---|
HC group | SCD patient group | |||||
MCA | ACA | PCA | MCA | ACA | PCA | |
Step CVR (%/mmHg) | 0.253 (0.046) | 0.235 (0.051) | 0.36 (0.068) | 0.178 (0.049) | 0.153 (0.056) | 0.259 (0.074) |
Ramp CVR (%/mmHg) | 0.274 (0.037) | 0.269 (0.047) | 0.382 (0.049) | 0.2 (0.054) | 0.188 (0.066) | 0.274 (0.079) |
Amplitude (a.u.) | 0.104 (0.015) | 0.103 (0.015) | 0.12 (0.016) | 0.087 (0.018) | 0.083 (0.019) | 0.111 (0.024) |
Midpoint (mmHg) | 39.7 (2.3) | 39.6 (2.4) | 40.2 (2.9) | 40.7 (2.7) | 40.6 (2.6) | 41.2 (3.1) |
Range (a.u.) | 4.4 (0.6) | 4.3 (0.5) | 4.0 (0.60) | 3.8 (0.6) | 3.7 (0.7) | 3.7 (0.7) |
Reserve (a.u.) | 0.048 (0.011) | 0.046 (0.014) | 0.064 (0.016) | 0.039 (0.010) | 0.036 (0.009) | 0.057 (0.015) |
Sensitivity (a.u.) | 0.373 (0.051) | 0.37 (0.064) | 0.491 (0.091) | 0.34 (0.067) | 0.33 (0.081) | 0.46 (0.098) |
Quality | 0.84 (0.044) | 0.84 (0.046) | 0.806 (0.056) | 0.776 (0.074) | 0.773 (0.087) | 0.751 (0.077) |
Regions of interest with significant difference (p < 0.001) between the SCD patient group and the healthy control are shown in bold.